Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location‐F study-Reference-Cited by-同舟云学术

Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location‐F study

Published:2023-12-11 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Choe Hun Jee¹^ORCID,Oh He Ran²,Bu Dawei³,An Ningyan⁴,Scherer Philipp E.³,An Zhiqiang⁴,Lim Soo¹^ORCID

Affiliation:

1. Department of Internal Medicine Seoul National University College of Medicine Seoul South Korea

2. Department of Internal Medicine Seoul National University Bundang Hospital Seongnam South Korea

3. Touchstone Diabetes Center The University of Texas Southwestern Medical Center Dallas Texas USA

4. Touchstone Diabetes Center The University of Texas Health Science Center at Houston Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases Houston Texas USA

Funder

Seoul National University Bundang Hospital

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference13 articles.

1. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

2. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

3. Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors

4. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes;Journal of Diabetes Investigation;2024-04-27